CD103+ CD8+ T cells are associated with an epithelial-derived carcinoma prognosis11 and CD103 alone contributes to prolonged survival in patients with bladder cancer26, ovarian cancer27, non-small cell lung cancer28, and melanoma29. The gene discussed is CD8A; the disease is carcinoma.